Fidelity Investments
LFSC

Fidelity Investments’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Fidelity Investments’s Portfolio LFSC Stock Details LFSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36K Buy
+30
New +$1.16K ﹤0.01% 5200

Other funds holding LFSC

EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
CCWP
Cedar Cove Wealth Partners Bloomington, Minnesota $213M AUM
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
OPA
Old Port Advisors Portland, Maine $508M AUM 50.99% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Fidelity Investments's LFSC Position: Q2 2026 in Review

Fidelity Investments opened a new position in F/m Emerald Life Sciences Innovation ETF (LFSC) in Q2 2026: 30 shares worth $1.36K. The stake represents ﹤0.01% of the portfolio and ranks #5200 among its holdings.

8 funds tracked by Wall St. Rank hold LFSC as of Q2 2026.

  • Fidelity Investments held 30 shares of F/m Emerald Life Sciences Innovation ETF worth $1.36K as of Q2 2026.
  • F/m Emerald Life Sciences Innovation ETF was a new Fidelity Investments position in Q2 2026.
  • F/m Emerald Life Sciences Innovation ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5200 holding.
  • 8 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.